• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC

New Search Back to Search Results
Note: this medical device has supplements. The device description may have changed. Be sure to look at the supplements to get an up-to-date view of this device.
Classification Namestent, renal
Generic Namestent, renal
750 daniels way
p.o. box 489
bloomington, IN 47402-0489
PMA NumberP100028
Date Received07/19/2010
Decision Date01/14/2011
Product Code
NIN[ Registered Establishments with NIN ]
Docket Number 11M-0056
Notice Date 01/26/2011
Advisory Committee Cardiovascular
Clinical Trials NCT00631540
Expedited Review Granted? No
Combination Product No
Approval Order Statement 
Approval for the formula balloon- expandable renal stent system. This device is indicated for use in patients with atherosclerotic disease of the renal arteries following sub-optimal percutaneous transluminal renal angioplasty (ptra) of a de novo or restenotic lesion (<= 18 mm in length) located within 10 mm of the renal ostium and with a reference vessel diameter of 4. 0 - 7. 0 mm. Supoptimal ptra is defined as >= 50% residual stenosis, >= 20 mmhg systolic or >= 10 mmhg mean translesional pressure gradient, or flow-limiting dissection.
Approval Order Approval Order
Summary Summary of Safety and Effectiveness
Labeling Labeling
Post-Approval StudyShow Report Schedule and Study Progress
Supplements: S001 S002 S003 S004